These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12475549)

  • 1. Hereditary risk of women's cancers.
    Frank TS; Critchfield GC
    Best Pract Res Clin Obstet Gynaecol; 2002 Oct; 16(5):703-13. PubMed ID: 12475549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
    Lu KH
    Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based genetic testing for Women's cancer prevention.
    Evans O; Gaba F; Manchanda R
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():139-153. PubMed ID: 32245629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing by cancer site: ovary.
    Weissman SM; Weiss SM; Newlin AC
    Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing.
    Rubin SC; Blackwood MA; Bandera C; Behbakht K; Benjamin I; Rebbeck TR; Boyd J
    Am J Obstet Gynecol; 1998 Apr; 178(4):670-7. PubMed ID: 9579428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic predisposition and ovarian cancer].
    Coupier I; Gauthier-Villars M; This P; Stoppa-Lyonnet D
    Rev Prat; 2004 Oct; 54(16):1757-62. PubMed ID: 15630879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic surgery of mammary and ovarian carcinoma].
    Lux MP; Bani MR; Fasching PA; Beckmann MW
    Chirurg; 2005 Dec; 76(12):1145-54. PubMed ID: 16237564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance estimates for
    Evans DG; Woodward E; Harkness EF; Howell A; Plaskocinska I; Maher ER; Tischkowitz MD; Lalloo F
    J Med Genet; 2018 Jul; 55(7):442-448. PubMed ID: 29483236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.
    South SA; Vance H; Farrell C; DiCioccio RA; Fahey C; Piver MS; Rodabaugh KJ
    Cancer; 2009 Jan; 115(2):324-33. PubMed ID: 19117025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary cancer syndromes.
    Fostira F; Thodi G; Konstantopoulou I; Sandaltzopoulos R; Yannoukakos D
    J BUON; 2007 Sep; 12 Suppl 1():S13-22. PubMed ID: 17935271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer.
    Watson P; Narod SA; Fodde R; Wagner A; Lynch JF; Tinley ST; Snyder CL; Coronel SA; Riley B; Kinarsky Y; Lynch HT
    J Med Genet; 2003 Aug; 40(8):591-6. PubMed ID: 12920070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary gynecologic cancers.
    Mutch D; Denny L; Quinn M;
    Int J Gynaecol Obstet; 2014 Mar; 124(3):189-92. PubMed ID: 24429354
    [No Abstract]   [Full Text] [Related]  

  • 18. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
    Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
    Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations for the management of women with an increased genetic risk of gynaecological cancer].
    Verheijen RH; Boonstra H; Menko FH; de Graaff J; Vasen HF; Kenter GG
    Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2414-8. PubMed ID: 12518519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
    Howarth DR; Lum SS; Esquivel P; Garberoglio CA; Senthil M; Solomon NL
    Am Surg; 2015 Oct; 81(10):941-4. PubMed ID: 26463285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.